FDA Adverse Event Malfunction Summary report: N

ENTERALITE INFINITY ENTERAL FEEDING PUMP

MDR report key: 21048817 · Received December 31, 2024

Report

Report Number
1722139-2024-00722
Event Type
Malfunction
Date Received
December 31, 2024
Date of Event
December 6, 2024
Report Date
December 6, 2024
Manufacturer
MOOG MEDICAL DEVICES GROUP
Product Code
LZH
UDI-DI
10814844000075
PMA / PMN Number
K031199
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS NOT RETURNED TO MMD FOR EVALUATION. A DHR REVIEW WAS COMPLETED AND NO NON-CONFORMANCES WERE FOUND. BECAUSE THE DEVICE WAS NOT RETURNED TO MMD FOR EVALUATION, AN INVESTIGATION COULD NOT BE COMPLETED. THIS REPORT WILL BE UPDATED IF THE DEVICE IS RETURNED TO MMDG.

Additional Manufacturer Narrative · 0

THE DEVICE WAS RETURNED TO MMD FOR EVALUATION. A DHR REVIEW WAS COMPLETED AND NO NON-CONFORMANCES WERE FOUND. WHEN THE DEVICE WAS RETURNED TO MMD FOR INVESTIGATION, IT OPERATED AS EXPECTED. MMD COULD NOT REPLICATE OR CONFIRM THE REPORTED COMPLAINT. BASED ON THIS INFORMATION, NO MDR WOULD HAVE BEEN REQUIRED.

Description of Event or Problem · 0

THE INITIAL REPORTER STATED THAT THE PUMP UNDER INFUSED AT A RATE THE MMD WOULD CONSIDER REPORTABLE. MMD DID FOLLOW UP WITH THE INITIAL REPORTER, WHO STATED THAT THE PATIENT HAD NOT EXPERIENCED ANY ADVERSE EFFECTS DUE TO THE COMPLAINT. NO ADDITIONAL INFORMATION WAS PROVIDED. [COMPLAINT-(B)(4).

Description of Event or Problem · 0

THE INITIAL REPORTER STATED THAT THE PUMP UNDER INFUSED AT A RATE THE MMD WOULD CONSIDER REPORTABLE. MMD DID FOLLOW UP WITH THE INITIAL REPORTER, WHO STATED THAT THE PATIENT HAD NOT EXPERIENCED ANY ADVERSE EFFECTS DUE TO THE COMPLAINT. NO ADDITIONAL INFORMATION WAS PROVIDED. [COMPLAINT(B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1207439 ENTERALITE INFINITY ENTERAL FEEDING PUMP ENTERAL INFUSION PUMP LZH MOOG MEDICAL DEVICES GROUP INFKIT2 N/A 10814844000075

Patients

Seq Age Sex Outcome Treatment
1 23 YR Prefer Not To Disclose